Possible future advances in treatment


One of the strongest arguments in favour of performing rib resection in all cases of localized empyema is that this provides an opportunity to remove all the fibrin from the cavity. It is now possible to obtain commercially enzymes which are capable of breaking down within the human body the solid constituents of an inflammatory exudate. These enzymes, which are derived from the culture of haemolytic streptococci, are known as streptokinase and streptodornase. The former breaks down fibrin and the latter leads to the
dissolution of desoxyribose nucleoprotein, which is largely responsible for the viscosity of pus (Sherry, Tillett, and Read, 1950). It is possible that the intrapleural injection of these enzymes may obviate the necessity for drainage of some cases of acute empyema but it would be unwise to recommend this as a routine form of treatment until these ferments have received more extensive trial. They are likely to be of particular value in empyemas which arise from infection of a haemothorax.
During recent years some surgeons have tried to reduce the period of con­valescence by first sterilizing the empyema with intrapleural chemotherapy and then treating the residual cavity by decortication (see page 44). Complete decortication followed by an uncomplicated convalescence certainly gives quick results but decortication is a major operation compared with rib-resection drainage and is not always followed by complete and rapid re-expansion of the lung. It is therefore advisable to reserve this form of treatment for those patients who are seen in the first instance several weeks after the optimum time for external drainage.